Prosus’s red report card for underperformers Byju’s, PharmEasy
This is the third time Prosus has marked down its valuation of the beleaguered edtech firm within a year.
November 30, 2023•1 min
0
November 30, 2023•1 min
0
More in
Business
Infra.Market is a hamster wheel looking at a make-or-break IPO
The construction material supply firm’s scale and profitability may appear shiny, but hide a stark truth. Its use of equity to fund working capital is playing with fire when bigger fish are eyeing its business.
You may also like
Business
Infra.Market is a hamster wheel looking at a make-or-break IPO
The construction material supply firm’s scale and profitability may appear shiny, but hide a stark truth. Its use of equity to fund working capital is playing with fire when bigger fish are eyeing its business.
Business
B.R. Shetty gets called out in Dubai for lying under oath
A Dubai court’s verdict against the disgraced NMC founder, XPANCEO’s new, expanded laboratory and other headlines from the week.
Business
Can private equity build the next Max Hospital in Kerala?
Global investors are betting on Kerala’s healthcare boom. But it remains to be seen whether private capital can coexist with the state’s public ethos.